Comment by
navajojoe on Jun 27, 2022 8:39am
This post has been removed in accordance with Community Policy
Comment by
navajojoe on Jun 27, 2022 9:25am
This post has been removed in accordance with Community Policy
Comment by
Pareto8020 on Jun 27, 2022 10:46am
Hopefully the new CEO has a little more savvy running a company and desiminating info than the current one. The appointment of a new CEO - if it is the right one- could be a real boost to Sirona and it's share price.
Comment by
MirrorWorldMan on Jun 27, 2022 12:53pm
New CEO is the perfect choice, as long as Howie doesn't fire him for creating insights thay Howie doesn't like. I would remove Howie from position of authority and keep him as a board member only, but he is too vane for that
Comment by
lscfa on Jun 27, 2022 10:54am
PRC can't even get it right. After the clinical study was public Sirona moved away from the phrase skin lightening and only talks about dark spots. quote=navajojoe] The problem is, PRC is apparently a shareholder, and yet has info we don't? That is not acceptable.[/quote]
Comment by
Pareto8020 on Jun 27, 2022 11:02am
Howard seems to be using PRC as more of a promo company than anything. Why are they paying CURE then? Goes to a long list of zigs when they should have been zagging. Said it before - a CEO shouldn't be a learn as you go position. Been too many obvious mistakes, wrong turns and plain old fashioned mismanagement at the shareholders expense.
Comment by
Engcan77 on Jun 27, 2022 11:02am
'Skin lightening' is now wording that not looked at in a good way.
Comment by
lscfa on Jun 27, 2022 11:05am
Results TFC-1067 and 2% hydroquinone produced statistically significant skin lightening after 8 weeks of use, but only hydroquinone lightened the normal skin. This pattern continued into week 12 where both products significantly lightened dyschromic skin, but hydroquinone also lightened the normal skin, which is not always desirable.
Comment by
navajojoe on Jun 27, 2022 2:18pm
This post has been removed in accordance with Community Policy